This inventor holds 1 USPTO granted patent. Top assignee: Nanohybrid Co., Ltd.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Ji-Young Yu
Introduction
Ji-Young Yu is a prominent inventor based in Seoul, South Korea. She has made significant strides in the field of cancer treatment through her innovative research and development. Her work focuses on creating effective and targeted therapies that can improve patient outcomes.
Latest Patents
Ji-Young Yu holds a patent for a "Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof." This novel cyclotriphosphazene-platinum(II) complex conjugate anticancer agent demonstrates high selectivity to tumor tissues. The enhanced permeability and retention effect in tumor tissues make this agent a promising candidate for cancer therapy.
Career Highlights
Ji-Young Yu is associated with Nanohybrid Co., Ltd., where she continues to contribute to advancements in medical technology. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
She collaborates with notable colleagues, including Youn-Soo Sohn and Yong-Joo Jun, who share her commitment to advancing cancer treatment solutions.
Conclusion
Ji-Young Yu's contributions to the field of cancer research exemplify the impact of innovative thinking in medicine. Her work not only highlights her expertise but also offers hope for improved cancer therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile